These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21468514)

  • 1. Tissue-specific effects of mutations in the thyroid hormone transporter MCT8.
    Kersseboom S; Visser TJ
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):1-5. PubMed ID: 21468514
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel mutation in MCT8 gene in a Brazilian boy with thyroid hormone resistance and severe neurologic abnormalities.
    Filho HC; Marui S; Manna TD; Brust ES; Radonsky V; Kuperman H; Dichtchekenian V; Setian N; Damiani D
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):60-6. PubMed ID: 21468521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of thyroid hormone analogues.
    Visser WE
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):170-172. PubMed ID: 32197712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation.
    Friesema EC; Grueters A; Biebermann H; Krude H; von Moers A; Reeser M; Barrett TG; Mancilla EE; Svensson J; Kester MH; Kuiper GG; Balkassmi S; Uitterlinden AG; Koehrle J; Rodien P; Halestrap AP; Visser TJ
    Lancet; 2004 Oct 16-22; 364(9443):1435-7. PubMed ID: 15488219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes.
    Groeneweg S; Peeters RP; Visser TJ; Visser WE
    Mol Cell Endocrinol; 2017 Dec; 458():82-90. PubMed ID: 28235578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone transport in and out of cells.
    Visser WE; Friesema EC; Jansen J; Visser TJ
    Trends Endocrinol Metab; 2008 Mar; 19(2):50-6. PubMed ID: 18291666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone transporters.
    Visser TJ
    Horm Res; 2007; 68 Suppl 5():28-30. PubMed ID: 18174701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone transporters and resistance.
    Visser TJ
    Endocr Dev; 2013; 24():1-10. PubMed ID: 23392090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone transporters--functions and clinical implications.
    Bernal J; Guadaño-Ferraz A; Morte B
    Nat Rev Endocrinol; 2015 Jul; 11(7):406-17. PubMed ID: 25942657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone transporters in health and disease.
    Jansen J; Friesema EC; Milici C; Visser TJ
    Thyroid; 2005 Aug; 15(8):757-68. PubMed ID: 16131319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene.
    Herzovich V; Vaiani E; Marino R; Dratler G; Lazzati JM; Tilitzky S; Ramirez P; Iorcansky S; Rivarola MA; Belgorosky A
    Horm Res; 2007; 67(1):1-6. PubMed ID: 16974106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8.
    Wémeau JL; Pigeyre M; Proust-Lemoine E; d'Herbomez M; Gottrand F; Jansen J; Visser TJ; Ladsous M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2084-8. PubMed ID: 18334584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy.
    Wirth EK; Sheu SY; Chiu-Ugalde J; Sapin R; Klein MO; Mossbrugger I; Quintanilla-Martinez L; de Angelis MH; Krude H; Riebel T; Rothe K; Köhrle J; Schmid KW; Schweizer U; Grüters A
    Eur J Endocrinol; 2011 Oct; 165(4):555-61. PubMed ID: 21813593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Activation of Pathogenic ΔPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones.
    Braun D; Schweizer U
    Endocrinology; 2015 Dec; 156(12):4720-30. PubMed ID: 26368820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter.
    Maranduba CM; Friesema EC; Kok F; Kester MH; Jansen J; Sertié AL; Passos-Bueno MR; Visser TJ
    J Med Genet; 2006 May; 43(5):457-60. PubMed ID: 15980113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8.
    Biebermann H; Ambrugger P; Tarnow P; von Moers A; Schweizer U; Grueters A
    Eur J Endocrinol; 2005 Sep; 153(3):359-66. PubMed ID: 16131597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone transport in developing brain.
    Bernal J
    Curr Opin Endocrinol Diabetes Obes; 2011 Oct; 18(5):295-9. PubMed ID: 21825978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impaired sensitivity to thyroid hormone].
    Kvistad SA; Methlie P; Løvås K; Sagen JV
    Tidsskr Nor Laegeforen; 2016 Apr; 136(7):618-22. PubMed ID: 27094663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Chemical Chaperones on Thyroid Hormone Transport by MCT8 Mutants in Patient-Derived Fibroblasts.
    Groeneweg S; van den Berge A; Meima ME; Peeters RP; Visser TJ; Visser WE
    Endocrinology; 2018 Mar; 159(3):1290-1302. PubMed ID: 29309566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.